BECTON, DICKINSON AND COMPANY Product Liability Accrual, Period Expense
BECTON, DICKINSON AND COMPANY (BDX) reported Product Liability Accrual, Period Expense of -$36.00 million for the 12-month period ending 2024-09-30, per its 10-K filed 2024-11-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProductLiabilityAccrualPeriodExpense · last filed 2024-11-27
- BECTON, DICKINSON AND COMPANY product liability accrual, period expense for the quarter ending 2023-12-31 was -$41.00M.
- BECTON, DICKINSON AND COMPANY product liability accrual, period expense for fiscal 2024 was -$36.00M.
- BECTON, DICKINSON AND COMPANY product liability accrual, period expense for fiscal 2022 was $21.00M, a 94.18% decline from fiscal 2021.
- BECTON, DICKINSON AND COMPANY product liability accrual, period expense for fiscal 2021 was $361.00M.
| Period end | Product Liability Accrual, Period Expense 3 month | Product Liability Accrual, Period Expense 12 month |
|---|---|---|
| 2024-09-30 | -$36.00M 10-K · filed 2024-11-27 | |
| 2023-12-31 | -$41.00M 10-Q · filed 2024-08-01 | |
| 2022-09-30 | $21.00M 10-K · filed 2022-11-22 | |
| 2021-09-30 | $361.00M 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |